Add to My Stocks
$3.34 $0.02 (0.6%) FLGT stock closing price Sep 20, 2018 (Closing)

The financial analysis of FLGT requires an investor to check the cash flows for FULGENT GENETIC. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about FULGENT GENETIC profits and FULGENT GENETIC debt. The cash flow statement is essetial while conducting the FULGENT GENETIC cash flow analysis and can be used to measure the operating performance of FULGENT GENETIC compared to various industry peers like MOTS stock and BTCY stock. The cash from operating activities for FULGENT GENETIC is $ 2017, which saw a decrease from previous year.

View details of FULGENT GENETIC cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2017201620152014
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.09M1.23M--
Net Increase (Decrease) in Assets Liabilities-0.71M-1.85M-1.74M-0.32M
Cash From (used in) Discontinued Operations--0.07M--0.02M
Other Adjustments Net2.45M10.44M8.18M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-5.35M-3.77M-2.03M-0.73M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments3.3M-39.01M--
Other Cash Inflow (Outflow) from Investment Activities---0.17M-0.04M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-24.81M3.5M4M
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-0.8M20.97M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year7.89M--1.34M
Cash & Equivalents at Year End6.49M7.89M--
All figures in USD. M: Millions of USD, B: Billions of USD.

FULGENT GENETIC stock price history provides insight into historical stock price fluctuations, and FULGENT GENETIC stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that FULGENT GENETIC is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - FULGENT GENETIC stock price movement.
  • The cash generated from the core business or operations was a positive at $1.33M for FULGENT GENETIC in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-2.04M for FLGT in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-0.77M for FULGENT GENETIC.

Key Financial Ratios For FULGENT GENETIC Cash Flow

Annual Cash Flow Statements For FULGENT GENETIC Peers

Digirad cash flow, MOTUS GI HLDGS cash flow, Omnicomm Systems cash flow